What is Prescript Assist?
Prescript-Assist® (P-A) is a next-generation combination of 29 probiotic microflora “Soil-Based-Organisms (SBOs)” uniquely combined with a humic/fulvic acid prebiotic that enhances SBO proliferation. Prescript-Assist’s® microflora are Class-1 micro ecological units that are typical of those progressively found resident along the healthy human GI Tract. And, with more than 5 years in clinical development and testing*, Prescript-Assist remains one of the most effective probiotic supplements for restoring levels of gastrointestinal micro-flora compromised from antibiotics, medication, poor diet, stress, and digestive abnormalities.
*Prescript-Assist Probiotic was the subject of a randomized, placebo controlled, double-blind clinical study (Clinical Therapeutics 2005; Vol 27, No. 6, Pgs.755-761.)
Pre and Probiotics can be derived as part of a natural diet from fermented foods like kimchee, sauerkrauet and kefir. When these are inaccessible or in times of acute need, supplements are the better option
- Maintains Healthy GI-Tract MicroFloral Ecologies
- Promotes Normal Bowel Function
- Supports Gut Immune-System
- Assists in Stabilizing the Gut Mucosal Barrier
- Supports Normal Absorption and Assimilation of Nutrients in the Gut
Take 2 per capsules of Prescript-Assist per day for the first 30 days, followed by 1 to 2 capsules per day thereafter, or as recommended by your healthcare professional. A minimum full 30 day cycle of 2 caps per day should be used to reconstitute beneficial gut flora following any antibiotic regimen.
Each 600mg capsule of Prescript-Assist® contains a proprietary blend of Leonardite, and the following microorganisms: Arthrobacter agilis, Arthrobacter citreus, Arthrobacter globiformis, Arthrobacter luteus, Arthrobacter simplex, Acinetobacter calcoaceticus, Azotobacter chroococcum, Azotobacter paspali, Azospirillum brasiliense, Azospirillum lipoferum, Bacillus brevis, Bacillus marcerans, Bacillus pumilus, Bacillus polymyxa, Bacillus subtilis, Bacteroides lipolyticum, Bacteriodes succinogenes, Brevibacterium lipolyticum, Brevibacterium stationis, Kurthia zopfii, Myrothecium verrucaria, Pseudomonas calcis, Pseudomonas dentrificans, Pseudomonas fluorescens, Pseudomonas glathei, Phanerochaete chrysosporium, Streptomyces fradiae, Streptomyces cellulosae, Streptomyces griseoflavus
Other Ingredients: cellulose (vegetarian capsule), l-leucine, bamboo (Bambusa vulgaris) extract
A primary objective of probiotic therapy is to provide therapeutic resistance against pathogen colonization in the GI tract. Prescript-Assist® is unique in this regard as its constituent microflora are representative of those found resident along the healthy human GI tract (vs. most common probiotic products). Its beneficial/healthy microflora, coupled with a proprietary prebiotic, provide for robust maintenance/enhancement of gut microflora and resistance to pathogenesis. Prescript-Assist’s® microflora arguably contribute to better health in their in-vitro and in-vivo demonstrated abilities to produce vital nutritional components (antioxidants, enzymes, amino acids, vitamins, etc). Quite unlike most probiotics that incorporate easily degradable lactic acid based microorganisms, the utilization of SBO's in Prescript-Assist® provides for a pH resistant (able to survive trip through the stomach) and shelf stable (does not need refrigeration) product.
This study identified 3 subsyndromic factors of IBS: general ill feelings/nausea, indigestion/flatulence, and colitis. In this methodologically oriented double-blind study in patients with IBS, combined probiotic-prebiotic treatment with Prescript-Assist was associated with significant reductions in these factors. http://www.ncbi.nlm.nih.gov/pubmed/16117982
Based on the results from the present 1-year extension study, treatment with this probiotic-prebiotic complex may be an option for short-term (2-4 weeks) and long-term ( approximately 60-week) reductions in IBS symptoms. http://www.ncbi.nlm.nih.gov/pubmed/17692729
It is clear that the vagus nerve,immune signaling, and the production of bioactive metabolites are strongly implicated in communication across the microbiota–gut–brain axis. More than a Gut Feeling: the Microbiota Regulates Neurodevelopment and Behavior.
Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. The suppression of the neuroendocrine stress response and the increase in the processing of positive versus negative attentional vigilance in subjects supplemented with B-GOS are consistent with previous findings of endocrine and anxiolytic effects of microbiota proliferation. http://www.ncbi.nlm.nih.gov/pubmed/25449699
As a result of the research activity that followed the publication of the prebiotic concept 15 years ago, it has become clear that products that cause a selective modification in the gut microbiota's composition and/or activity(ies) and thus strengthens normobiosis could either induce beneficial physiological effects in the colon and also in extra-intestinal compartments or contribute towards reducing the risk of dysbiosis and associated intestinal and systemic pathologies. http://www.ncbi.nlm.nih.gov/pubmed/20920376
Further Reading: Gut Feeling: How Intestinal Bacterial Could Manipulate Your Brain http://www.theatlantic.com/health/archive/2014/09/when-yogurt-affects-the-brain/380542/